BridgeMD
An investigation of heart-lung support without blood thinners during lung transplantation.
EU CTIS ID: 2024-519503-10-00
What this study is testing
To investigate the feasibility of running heparin free VA-ECMO support during clinical lung transplantation and its effect on clinical outcomes and inflammatory response
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Adult recipients over the age of 18 at the time of the procedure, receiving a double lung transplantation (including lungs after ex-vivo lung perfusion) within the Vienna Lung Transplant Program
- Informed consent
You likely can't join if
- Single lung transplantation
- Re-transplantation
- Previous major thoracic surgery (excluding pleural drainage, VATS biopsy)
- ECMO bridge to transplantation
- COVID-ARDS as transplant indication
- Pre-operative anti- coagulation/anti-platelet treatment
See the full eligibility criteria
- Adult recipients over the age of 18 at the time of the procedure, receiving a double lung transplantation (including lungs after ex-vivo lung perfusion) within the Vienna Lung Transplant Program
- Informed consent
- Single lung transplantation
- Re-transplantation
- Previous major thoracic surgery (excluding pleural drainage, VATS biopsy)
- ECMO bridge to transplantation
- COVID-ARDS as transplant indication
- Pre-operative anti- coagulation/anti-platelet treatment
- Paediatric transplantation
- Multi- organ transplantation
- Active pregnancy or breastfeeding
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.